Emma Hall, Professor of Oncology Trials is Deputy Director of the Cancer Research UK-funded Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU). She is a chartered statistician with over 20 years’ experience in the design, methodology and analysis of oncology clinical trials.
She is a member of the National Clinical Research Institute (NCRI)’s Bladder & Renal cancers Research Group and its Clinical and Translational Radiotherapy Research Group (CTRad) Workstream 3 (Phase 3 Trials and Methodology). She is also a member of CTRad’s Proton Beam Clinical Trial Strategy Group. She leads the methodology workstream of the Cancer Research UK funded Advanced Radiotherapy Network.
Professor Hall sits on the independent data monitoring and trial steering committees for a number of international and national clinical trials and is a member of the Marie Curie Research Funding Committee. She leads the ICR-CTSU’s portfolio of research in urological and head and neck cancers.
Her current research interests includes the design and analysis of radiotherapy trials, novel agent/biomarker studies in metastatic castrate resistance prostate cancer and trials evaluating the treatment and management of prostate, bladder and rarer genitourinary cancers.